Nilotinib alters action potentials in human iPSC-derived cardiomyocytes
Cell-based study · ArcLight-expressing human induced pluripotent stem cell-derived cardiomyocytes [2]
At 1 μM, nilotinib prolonged optical APD90 and produced early afterdepolarizations. This is a cellular safety-pharmacology observation, not a clinical risk estimate.
| Endpoint | Reported result | Reference |
|---|---|---|
| Optical action-potential duration at 90% repolarization | APD90 Baseline 470 ± 36 ms; nilotinib 821 ± 79 ms; mean ± SEM; n = 17 cells in three independent experiments; p < 0.01 | [2] |
| Cells developing early afterdepolarizations | Frequency 18% of ArcLight-hiPSC-CMs | [2] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 1 μM
- Exposure duration
- 1 hr in Results and Figure 4D; general optical-imaging methods specify 60–90 min for nilotinib.
- Method
- Application to Tyrode’s solution followed by optical recording.
- Vehicle
- DMSO; identical 0.1% DMSO used as vehicle controls.
- Reported limits
- Exact salt/form, catalog number and lot are not specified in the read main text; supplemental methods were not read. No vehicle-only numerical APD90 result is supplied in the adopted main-text result/figure.
Methods and source locations
Compound reported in the paper: Nilotinib; Compound label in the paper: Nilotinib (Adooq Bioscience)
Applicable to the named research compound. Does not establish free-base versus salt equivalence or validate a present A10644 lot.
Results: Drug Testing Using ArcLight-hiPSC-CMs; Figure 4D and caption; Experimental Procedures: Pharmacological Studies, Optical Imaging, Statistical Analysis
Optical action-potential duration at 90% repolarization: ArcLight optical recordings; paired Student’s t test against baseline. — Results: Drug Testing Using ArcLight-hiPSC-CMs; Figure 4D and caption; Experimental Procedures: Pharmacological Studies, Optical Imaging, Statistical Analysis
Cells developing early afterdepolarizations: ArcLight optical recordings; frequency reported in Results. — Results: Drug Testing Using ArcLight-hiPSC-CMs; Figure 4D and caption; Experimental Procedures: Pharmacological Studies, Optical Imaging, Statistical Analysis